0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Galectin Therapeutics Inc - Trending symbols

Latest News of Galectin Therapeutics Inc

DateTitleRead
2025-06-17
13:20
Galectin Therapeutics stock rating initiated at buy by H.C. WainwrightRead

Notifications

TypeNotificationDate
RSI OverboughtOverbought RSI (Relative Strength Index)2025-06-18



Trends

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Net Invested Capital 9,154-1039,0517999,850-8,917933-7,498-6,565
Net Working Capital 12,03479312,827-15712,670-9,2623,408-21,565-18,157
Total Other Income Expense Net -436-1,405-1,841761-1,080-1,074-2,1542,615461
Income Tax Expense 87-3651397448-24424-3,418-2,994
Net Debt -8,253-39,188-47,44120,343-27,09816,506-10,59231,86821,276
Total Stockholder Equity 6,89838,69745,595-15,99529,600-28,707893-34,810-33,917
Reconciled Depreciation 707182432-48-16
Depreciation and Amortization 10152513383876-92-16
Other Current Liabilities 2,360-5491,811-6911,1202,9434,063-25,883-21,820
Net Tangible Assets 17,707-2,84114,866-6,1448,722-8,356366-8,809-8,443
EBITDA -23,45617,150-6,306-1,876-8,182-51-8,2338,24411

Comments

How you think about this?

Leave a comment

Stay informed about Galectin Therapeutics Inc.

Receive notifications about Galectin Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.